132 related articles for article (PubMed ID: 28593629)
21. Fasting serum glucose level and cancer risk in Korean men and women.
Jee SH; Ohrr H; Sull JW; Yun JE; Ji M; Samet JM
JAMA; 2005 Jan; 293(2):194-202. PubMed ID: 15644546
[TBL] [Abstract][Full Text] [Related]
22. Intake of different dietary proteins and risk of type 2 diabetes in men: the Kuopio Ischaemic Heart Disease Risk Factor Study.
Virtanen HEK; Koskinen TT; Voutilainen S; Mursu J; Tuomainen TP; Kokko P; Virtanen JK
Br J Nutr; 2017 Mar; 117(6):882-893. PubMed ID: 28397639
[TBL] [Abstract][Full Text] [Related]
23. Anthropometric indices predicting incident type 2 diabetes in an Iranian population: the Isfahan Cohort Study.
Talaei M; Sadeghi M; Marshall T; Thomas GN; Iranipour R; Nazarat N; Sarrafzadegan N
Diabetes Metab; 2013 Oct; 39(5):424-31. PubMed ID: 23867722
[TBL] [Abstract][Full Text] [Related]
24. Multiple anthropometric measures in relation to incidence of diabetes: a Swedish population-based cohort study.
Borné Y; Nilsson PM; Melander O; Hedblad B; Engström G
Eur J Public Health; 2015 Dec; 25(6):1100-5. PubMed ID: 25817208
[TBL] [Abstract][Full Text] [Related]
25. 2 years change of waist circumference and body mass index and associations with type 2 diabetes mellitus in cohort populations.
Luo W; Guo Z; Hu X; Zhou Z; Wu M; Zhang L; Liu J
Obes Res Clin Pract; 2013; 7(4):e290-6. PubMed ID: 24306157
[TBL] [Abstract][Full Text] [Related]
26. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
27. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.
Simon TG; King LY; Chong DQ; Nguyen LH; Ma Y; VoPham T; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Khalili H; Chung RT; Zhang X; Chan AT
Hepatology; 2018 May; 67(5):1797-1806. PubMed ID: 29152763
[TBL] [Abstract][Full Text] [Related]
28. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort.
Maskarinec G; Shvetsov YB; Conroy SM; Haiman CA; Setiawan VW; Le Marchand L
Breast Cancer Res Treat; 2019 Feb; 173(3):637-645. PubMed ID: 30367331
[TBL] [Abstract][Full Text] [Related]
29. Body mass index and waist circumference as predictors of all-cause mortality in an Aboriginal Australian community.
Adegbija O; Hoy WE; Dong B; Wang Z
Obes Res Clin Pract; 2017; 11(1):19-26. PubMed ID: 27364234
[TBL] [Abstract][Full Text] [Related]
30. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
[TBL] [Abstract][Full Text] [Related]
31. Cancer risk in people with diabetes: Does physical activity and adiposity modify the association? Prospective data from the HUNT Study, Norway.
Moe B; Nilsen TI
J Diabetes Complications; 2015 Mar; 29(2):176-9. PubMed ID: 25534878
[TBL] [Abstract][Full Text] [Related]
32. Life-course social position, obesity and diabetes risk in the EPIC-Spain Cohort.
Cirera L; Huerta JM; Chirlaque MD; Molina-Montes E; Altzibar JM; Ardanaz E; Gavrila D; Colorado-Yohar S; Barricarte A; Arriola L; Quirós JR; Sánchez-Cantalejo E; Sánchez MJ; Agudo A; Navarro C
Eur J Public Health; 2016 Jun; 26(3):439-45. PubMed ID: 26635012
[TBL] [Abstract][Full Text] [Related]
33. Modifying Effect of Body Mass Index on Survival in Elderly Type 2 Diabetic Patients: Hong Kong Diabetes Registry.
Cheung KK; Jiang G; Lee JS; Luk AO; Kong AP; Ozaki R; Ting RZ; Ma RC; Chow FC; Chan JC; So WY
J Am Med Dir Assoc; 2016 Mar; 17(3):276.e15-22. PubMed ID: 26832126
[TBL] [Abstract][Full Text] [Related]
34. Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts.
Hu Y; Zhang X; Ma Y; Yuan C; Wang M; Wu K; Tabung FK; Tobias D; Hu FB; Giovannucci E; Song M
J Natl Cancer Inst; 2021 Apr; 113(4):381-389. PubMed ID: 33225344
[TBL] [Abstract][Full Text] [Related]
35. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality.
Melander O; Maisel AS; Almgren P; Manjer J; Belting M; Hedblad B; Engström G; Kilger U; Nilsson P; Bergmann A; Orho-Melander M
JAMA; 2012 Oct; 308(14):1469-75. PubMed ID: 23047361
[TBL] [Abstract][Full Text] [Related]
36. Excess body weight and cancer risk in patients with type 2 diabetes who were registered in Swedish National Diabetes Register--register-based cohort study in Sweden.
Miao Jonasson J; Cederholm J; Gudbjornsdottir S
PLoS One; 2014; 9(9):e105868. PubMed ID: 25198347
[TBL] [Abstract][Full Text] [Related]
37. Body mass index and the risk of mortality in type II diabetic patients from Verona.
Zoppini G; Verlato G; Leuzinger C; Zamboni C; Brun E; Bonora E; Muggeo M
Int J Obes Relat Metab Disord; 2003 Feb; 27(2):281-5. PubMed ID: 12587011
[TBL] [Abstract][Full Text] [Related]
38. Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort.
Maskarinec G; Haraldsdóttir Á; Einarsdóttir K; Aspelund T; Tryggvadóttir L; Harris TB; Gudnason V; Torfadóttir JE
Cancer Causes Control; 2019 Oct; 30(10):1057-1065. PubMed ID: 31401707
[TBL] [Abstract][Full Text] [Related]
39. Chronic Consumption of Artificial Sweetener in Packets or Tablets and Type 2 Diabetes Risk: Evidence from the E3N-European Prospective Investigation into Cancer and Nutrition Study.
Fagherazzi G; Gusto G; Affret A; Mancini FR; Dow C; Balkau B; Clavel-Chapelon F; Bonnet F; Boutron-Ruault MC
Ann Nutr Metab; 2017; 70(1):51-58. PubMed ID: 28214853
[TBL] [Abstract][Full Text] [Related]
40. Combined effect of adiposity and elevated inflammation on incident type 2 diabetes: a prospective cohort study.
Wu D; Lan Y; Chen S; Ding X; Chen G; Wu C; Balmer L; Xu W; Wu S; Wang W
Cardiovasc Diabetol; 2023 Dec; 22(1):351. PubMed ID: 38124083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
